Bioagilytix Labs
BioAgilytix Labs, a leading global bioanalytical laboratory, is headquartered in the United States and operates across major regions including Europe and Asia. Founded in 2008, the company has established itself in the biopharmaceutical industry, specialising in high-quality bioanalytical services that support drug development and regulatory submissions. With a focus on large molecule bioanalysis, BioAgilytix offers unique capabilities in pharmacokinetics, immunogenicity, and biomarker analysis. Their state-of-the-art technology and experienced team enable them to deliver precise and reliable results, setting them apart in a competitive market. Recognised for their commitment to quality and innovation, BioAgilytix Labs has achieved significant milestones, solidifying their position as a trusted partner for biopharmaceutical companies worldwide.
DitchCarbon Score
How does Bioagilytix Labs's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bioagilytix Labs's score of 8 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Bioagilytix Labs's reported carbon emissions
BioAgilytix Labs, headquartered in the United States, has made significant commitments towards reducing its carbon emissions, although specific emissions data is currently unavailable. The company has committed to achieving net-zero emissions across all scopes by 2050, with a starting point in 2023. This long-term target aligns with industry standards and reflects a proactive approach to climate action within the pharmaceuticals, biotechnology, and life sciences sector. BioAgilytix Labs is actively engaged in the Science Based Targets initiative (SBTi), demonstrating its commitment to science-based climate strategies. The company has established a near-term target status of "Committed," indicating a serious dedication to reducing its carbon footprint. While specific reduction percentages have not been disclosed, the overarching goal of net-zero emissions signifies a comprehensive strategy to mitigate climate impact. As the company progresses towards its climate commitments, it is positioned to contribute positively to the global effort against climate change, aligning with the increasing expectations for sustainability in the industry.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bioagilytix Labs is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
